Intech Investment Management LLC Aldeyra Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 23,806 shares of ALDX stock, worth $154,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,806
Previous 14,628
62.74%
Holding current value
$154,024
Previous $78,000
51.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALDX
# of Institutions
122Shares Held
36.3MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$60 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$35.4 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$24.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$23.4 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.47MShares$9.5 Million0.17% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $377M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...